Broadcrest Asset Management »

Bio-techne Corporation shares owned by Broadcrest Asset Management

Quarter-by-quarter ownership of Bio-techne Corporation (TECH) shares owned by Broadcrest Asset Management from 13F filings

Historical chart of Broadcrest Asset Management investment in Bio-techne Corporation

Tip: Access up to 7 years of quarterly data

All positions including Bio-techne Corporation held by Broadcrest Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-techne Corporation by Broadcrest Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 300k 77.16
2023-09-30 $19M 275k 68.07
2023-06-30 $25M 300k 81.63

More positions owned by Broadcrest Asset Management

Transcat, Inc. Cmn Common Stock (TRNS)
Bio-techne Corp Common Stock (TECH)
Heico Corp New-cl A Common Stock (HEI.A)
Tyler Technologies Common Stock (TYL)
Evi Industries Common Stock (EVI)
Nomad Holdings Common Stock (NOMD)

View all positions for Broadcrest Asset Management

Top funds holding Bio-techne Corporation

Vanguard Group
Bamco
Select Equity
Neuberger Berman Group
Df Dent & Co
Mairs and Power
T. Rowe Price Associates
Bank of New York Mellon
Mackenzie Financial
Marshall Wace
William Blair Investment Management
Wellington Management Company
Norges Bank Investment Management
Jackson Square Partners
Charles Schwab Investment Management

View all funds holding Bio-techne Corporation